Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

Etats-Unis|Canada
English|French

Biocept Inc

(NASDAQ: BIOC)
Ajouter à Portefeuille
+0,03 (+6,48%)
en date du nov 21, 2019

Profil
Symbole BIOC
Marché NASDAQ
Informations de contact
5810 Nancy Ridge Drive
San Diego, CA USA
P: 858-320-8200
Président Michael W. Nall
Bénéfices à vue d'oeuil
Bénéfices 09/30/19
-0.25
06/30/19
-0.38
03/31/19
-0.61
12/31/18
-0.56
Ratio prix/bénéfices N/A
Croissance du BPA N/A
Most Recent Earnings ($) -0,25
Annual EPS ($) -2,67
Résumé business
Biocept Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept Inc. is headquartered in San Diego California.
Industrie/Secteur Information not available.